Immune cholangitis: Liver allograft rejection and graft-versus-host disease

Mayo Clinic Proceedings

Volumn 73, Issue 4, 1998, Pages 367-379

  Demetris, Anthony J ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN FUNCTION; ARTERY DISEASE; CHOLANGITIS; CONFERENCE PAPER; EARLY DIAGNOSIS; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; LIVER INJURY; LIVER TRANSPLANTATION; TREATMENT PLANNING;

EID: 0031942221     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-6196(11)63705-1     Document Type: Conference Paper

References (177)

1. Appleton AL, Sviland L. Current thoughts on the pathogenesis of graft versus host disease [published erratum appears in J Clin Pathol 1994;47:96]. J Clin Pathol 1993;46:785-789
2. Hess AD, Jones RC, Santos GW. Autologous graft-vs-host disease: mechanisms and potential therapeutic effect. Bone Marrow Transplant 1993;12(Suppl 3):S65-S69
3. Antin JH, Ferrara JLM. Cytokine dysregulation and acute graftversus-host disease. Blood 1992:80:2964-2968
4. Vogelsang GB, Hess AD. Graft-versus-host disease: new directions for a persistent problem. Blood 1994;84:2061-2067
5. Sykes M. Novel approaches to the control of graft versus host disease. Curr Opin Immunol 1993;5:774-781
6. Bron D. Graft-versus-host disease. Curr Opin Oncol 1994;6:358-364
7. Giralt S, Weber D, Colome M, Dimopoulos M, Mehra R, Van Besien K, et al. Phase I trial of cyclosporine-induced autologous graftversus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue. J Clin Oncol 1997:15:667-673
8. Wolin MJ, Rigor RL. Acute graft-versus-host disease in a recipient of a twin blood cell transplant. Bone Marrow Transplant 1996;17:125-126
9. Gajewski J, Champlin R. Bone marrow transplantation from unrelated donors. Curr Opin Oncol 1996;8:84-88
10. Murata M, Kanie T, Taji H, Hamaguchi M, Minami S, Kodera Y. Comparative study of bone marrow transplantation from unrelated donors and identical sibling donors in a single institute. Rinsho Ketsueki 1996:37:1245-1252
11. Nagler A, Brautbar C, Slavin S, Bishara A. Bone marrow transplantation using unrelated and family related donors: the impact of HLAC disparity. Bone Marrow Transplant 1996;18:891-897
12. Spencer A, Szydlo RM, Brookes PA, Kaminski E, Rule S, van Rhee F, et al. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient. Blood 1995:86:3590-3597
13. Tabbara IA. Allogeneic bone marrow transplantation. South Med J 1996:89:857-868
14. Markus BH, Fung JJ, Gordon RD, Vanek M, Starzl TE, Duquesnoy RJ. HLA histocompatibility and liver transplant survival. Transplant Proc 1987;19(Suppl 3):63-65
15. Markus BH, Duquesnoy RJ, Gordon RD, Fung JJ, Vanek M, Klintmalm G, et al. Histocompatibility and liver transplant outcome: does HLA exert a dualistic effect? Transplantation 1988:46:372-377
16. Starzl TE, Demetris AJ, Trucco M. Matching and the black recipient. Transplant Proc 1993;25:2450-2451
17. Donaldson P, Underhill J, Doherty D, Hayllar K, Calne R, Tan KC, et al. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect." Hepatology 1993; 17:1008-1015
18. Teraski PI, editor. Clinical Transplants. Los Angeles: Regents of the University of California; 1994
19. Austyn JM, Steinman RM. The passenger leukocyte-a fresh look. Transplant Rev 1988;2:139-176
20. Demetris AJ, Sever C, Kakizoe S, Oguma S, Starzl TE, Jaffe R. S100 protein positive dendritic cells in primary biliary cirrhosis and other chronic inflammatory liver diseases: relevance to pathogenesis? Am J Pathol 1989:134:741-747
21. Lu L, Woo J, Rao AS, Li Y, Watkins SC, Qian S, et al. Propagation of dendritic cell progenitors from normal mouse liver using granulocytic/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med 1994;179:1823-1834
22. Prickett TCR, McKenzie JL, Hart DNJ. Characterization of interstitial dendritic cells in human liver. Transplantation 1988;46:754-761
23. van den Oord JJ, Volpes R, Desmet VJ. Dendritic cells and the liver. APMIS Suppl 1991:23:68-76
24. Hays EF, Hays DM, Golde DW. Hemopoietic stem cells in mouse liver. ExpHematol 1978;6:18-27
25. Murase N, Starzl TE, Ye Q, Tsamandas A, Thomson AW, Rao AS, et al. Multilineage hematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation: with particular reference to the liver. Transplantation 1996;61:1-4
26. Taniguchi H, Toyoshima T, Fukao K, Nakauchi H. Presence of hematopoietic stem cells in the adult liver. Nat Med 1996;2:198-203
27. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973;137:1142-1162
28. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J Exp Med 1974:139:380-397
29. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991:9:271-296
30. Egner W, Prickett TC, Hart DN. Adhesion molecule expression: a comparison of human blood dendritic cells, monocytes, and macrophages. Transplant Proc 1992;24:2318
31. Lu L, Rudert WA, Qian S, McCaslin D, Fu F, Rao AS, et al. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colonystimulating factor. J Exp Med 1995:182:379-387
32. Young JW, Koulova L, Soergel SA, Clark EA, Steinman RM, Dupont B. The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro [published erratum appears in J Clin Invest 1993:91:1853]. J Clin Invest 1992;90:229-237
33. Demetris AJ, Qian S, Sun H, Fung JJ, Yagihashi A, Murase N, et al. Early events in liver allograft rejection: delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization. Am J Pat/70/ 1991:138:609-618
34. Demetris AJ, Muràse N, Fujisaki S, Fung JJ, Rao AS, Starzl TE. Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc 1993:25:3337-3344
35. Sun J, McCaughan GW, Gallagher ND, Sheil AG, Bishop GA. Dele tion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation 1995:60:233-236
36. Parkman R. Is chronic graft versus host disease an autoimmune disease? Curr Opin Immunol 1993:5:800-803
37. Ferrara JLM, Cooke KR, Pan L, Krenger W. The immunopathophysiology of acute graft-versus-host-disease. Stem Cells 1996:14:473-489
38. Adams D. Immunological aspects of clinical liver transplantation. Immunol Lett 1991:29:69-72
39. de Groen PC, Kephart GM, Gleich GJ, Ludwig J. The eosinophil as an effector cell of the immune response during hepatic allograft rejection. Hepatology 1994:20:654-662
40. Hoffmann MW, Wonigeit K, Steinhoff G, Herzbeck H, Flad HD, Pichlmayr R. Production of cytokines (TNF-alpha, IL-1-beta) and endothelial cell activation in human liver allograft rejection. Transplantation 1993:55:329-335
41. Krams SM, Ascher NL, Martinez OM. New immunologic insights into mechanisms of allograft rejection. Gastroenterol Clin North Am 1993 Jun;22:381-400
42. Demetris AJ. Immunopathology of the human biliary tree. In: Sirica AE, Longnecker DS, editors. Pathobiology and Pathophysiology. New York: Marcel Dekker; 1997. pp 127-180
43. Hathaway M, Burnett D, Elias E, Adams DH. Secretion of soluble chemotactic factors, including interleukin-6: a mechanism for the recruitment of CDS-positive T lymphocytes to human liver allografts during rejection. Hepatology 1993:18:511-518
44. Vierling JM. Immunologic mechanisms of hepatic allograft rejection. Semin Liver Dis 1992;12:16-27
45. Platz KP, Mueller AR, Rossaint R, Steinmuller T, Lemmens HP, Lobeck H, et al. Cytokine pattern during rejection and infection after liver transplantation-improvements in postoperative monitoring? Transplantation 1996;62:1441-1450
46. Steinhoff G, Behrend M, Schrader B, Pichlmayr R. Intercellular immune adhesion molecules in human liver transplants: overview on expression patterns of leukocyte receptor and ligand molecules. Hepatology 1993; 18:440-453
47. Steinhoff G, Behrend M, Schrader B, Duijvestijn AM, Wonigeit K. Expression patterns of leukocyte adhesion ligand molecules on human liver endothelia: lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2, and LFA-3. Am J Pathol 1993:142:481-488
48. Martinez OM, Villanueva JC, Lake J, Roberts JP, Ascher NL, Krams SM. IL-2 and IL-5 gene expression in response to alloantigen in liver allograft recipients and in vitro. Transplantation 1993:55:1159-1166
49. Martinez OM, Krams SM, Sterneck M, Villanueva JC, Falco DA, Ferrell LD, et al. Intragraft cytokine profile during human liver allograft rejection. Transplantation 1992:53:449-456
50. Martinez OM, Ascher NL, Ferrell L, Villanueva J, Lake J, Roberts JP, et al. Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils. Transplantation 1993:55:909-918
51. Kunkel SL, Remick DG, Stricter RM, Larrick JW. Mechanisms that regulate the production and effects of tumor necrosis factor-alpha. Crit Rev Immunol 1989:9:93-117
52. Krams SM, Egawa H, Quinn MB, Villanueva JC, Garcia-Kennedy R, Martinez OM. Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation 1995:59:621-625
53. Saidman SL, Duquesnoy RJ, Zeevi A, Fung JJ, Starzl TE, Demetris AJ. Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes. Hepatology 1991:13:239-246
54. Ayres RC, Neuberger JM, Shaw J, Joplin R, Adams DH. Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines. Gut 1993:34:1245-1249
55. Hu W, Blazar BR, Manivel JC, Paradis K, Sharp HL. Phenotypical and functional characterization of intrahepatic bile duct cells from common duct ligated mice. J Lab Clin Med 1996:128:536-544
56. Roberts JP, Ascher NL, Lake J, Capper J, Purohit S, Garovoy M, et al. Graft vs. host disease after liver transplantation in humans: a report of four cases. Hepatology 1991:14:274-281
57. Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, lldstad S, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993:17:1127-1152
58. Sanchez-lzquierdo JA, Lumbreras C, Colina F, Martinez-Laso J, Jimenez C, Gomez R, et al. Severe graft versus host disease following liver transplantation confirmed by PCR-HLA-B sequencing: report of a case and literature review. Hepatogastroenterology 1996:43:1057-1061
59. Whitington PF, Rubin CM, Alonso EM, McKeithan TW, Anastasi J, Hart J, et al. Complete lymphoid chimerism and chronic graft-versushost disease in an infant recipient of a hepatic allograft from an HLAhomozygous parental living donor. Transplantation 1996:62:1516-1519
60. Collins RH Jr, Anastasi J, Terstappen LWMM, Nikaein A, Feng J, Fay JW, et al. Brief report: donor-derived long-term multilineage hematopoiesis in a liver-transplant recipient. N Engl J Med 1993:328:762-765
61. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994;19:916-924
62. Owen RD. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 1945:102:400-401
63. lldstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984;307:168-170
64. Hoffman AL, Makowka L, Cramer DV, Cai X, Banner B, Pascualone A, et al. Induction of stable chimerism and elimination of graftversus-host disease by depletion of T lymphocytes from bone marrow using immunomagnetic beads. Surgery 1989:106:354-363
65. Demetris AJ, IV-urase N, Rao AS, Starzl TE. The role of passenger leukocytes in rejection and "tolerance" after solid organ transplantation: a potential explanation of a paradox. In: Touraine J-L, Traeger J, Bétuel H, Dubernard JM, Revillard JP, Dupuy C, editors. Rejection and Tolerance. Dordrecht (Netherlands): Kluwer Academic Publishers; 1993. pp 325-392
66. Huss R, Deeg HJ, Gooley T, Bryant E, Leisenring W, Clift R, et al. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia. Bone Marrow Transplant 1996;18:767-776
67. Starzl TE, Demetris AJ, Murase N, lldstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992:339:1579-1582
68. Mackinnon S, Barnett L, Heller G, O'Reilly RJ. Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood 1994:83:3409-3416
69. Gaziev D, Polchi P, Galimberti M, Angelucci E, Giardini C, Baronciani D, et al. Graft-versus-host disease after bone marrow transplantation for thalassemia: an analysis of incidence and risk factors. Transplantation 1997:63:854-860
70. Hagglund H, Bostrom L, Remberger M, Ljungman P, Nilsson B, Ringden 0. Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients. Bone Marrow Transplant 1995:16:747-753
71. Arnold JC, Portmann BC, O'Grady JG, Naoumov NV, Alexander GJM, Williams R. Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome. Hepatology 1992;16:285-292
72. Cakaloglu Y, Devlin J, O'Grady J, Sutherland S, Portmann BC, Heaton N, et al. Importance of concomitant viral infection during late acute liver allograft rejection. Transplantation 1995;59:40-45
73. Manez R, White LT, Linden P, Kusne S, Martin M, Kramer D, et al. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation 1993;55:1067-1071
74. Manez R, White LT, Kusne S, Martin M, Demetris AJ, Starzl TE, et al. Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation. Transplant Proc 1993;25:908-909
75. Fennell RH Jr. Ductular damage in liver transplant rejection: its similarity to that of primary biliary cirrhosis and graft-versus-host disease. Pathol Annu 1981:16:289-294
76. Vierling JM, Fennell RH Jr. Histopathology of early and late human hepatic allograft rejection: evidence of progressive destruction of interlobular bile ducts. Hepatology 1985;5:1076-1082
77. Grond J, Gouw ASH, Poppema S, Slooff MJH, Gips CH. Chronic rejection in liver transplants: a histopathologic analysis of failed grafts and antecedent serial biopsies. Transplant Proc 1986;18(Suppl 4):128-135
78. Demetris AJ, Jaffe R, Starzl TE. A review of adult and pediatric posttransplant liver pathology. Pathol Annu 1987:22:347-386
79. Oguma S, Belle S, Starzl TE, Demetris AJ. A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss; direct immunologic and ischemic factors. Hepatology 1989:9:204-209
80. Batts KP, Moore SB, Perkins JD, Wiesner RH, Grambsch PM, Krom RAF. Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts. Transplantation 1988:45:376-379
81. Donaldson PT, Alexander GJ, O'Grady J, Neuberger J, Portmann B, Thick M, et al. Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet 1987:1:945-951
82. Ludwig J, Wiesner RH, Batts KP, Perkins JD, Krom RAF. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. Hepatology 1987:7:476-483
83. O'Grady JG, Alexander GJ, Sutherland S, Donaldson PT, Harvey F, Portmann B, et al. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet 1988:2:302-305
84. Demetris AJ, Qian SG, Sun H, Fung JJ. Liver allograft rejection: an overview of morphologic findings. Am J Surg Pathol 1990;14(Suppl l):49-63
85. Freese DK, Snover DC, Sharp HL, Gross CR, Savick SK, Payne WD. Chronic rejection after liver transplantation: a study of clinical, histopathological and immunological features. Hepatology 1991:13:882-891
86. van Hoek B, Wiesner RH, Krom RAF, Ludwig J, Moore SB. Severe ductopenic rejection following liver transplantation: incidence, time of onset, risk factors, treatment, and outcome. Semin Liver Dis 1992:12:41-50
87. Devlin JJ, O'Grady JG, Tan KC, Calne RY, Williams R. Ethnic variations in patient and graft survival after liver transplantation: identification of a new risk factor for chronic allograft rejection. Transplantation 1993;56:1381-1384
88. Lowes JR, Hubscher SG, Neuberger JM. Chronic rejection of the liver allograft. Gastroenterol Clin North Am 1993 Jun:22:401-420
89. Dousset B, Conti F, Houssin D, Calmus Y. Acute vanishing bile duct syndrome after Interferon therapy for recurrent HCV infection in livertransplant recipients [letter]. N Engl J Med 1994:330:1160-1161
90. Snover DC. Biopsy interpretation in bone marrow transplantation. Pathol Annu 1989:24:63-101
91. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993:328:593-602
92. Candinas D, Gunson BK, Nightingale P, Hubscher S, McMaster P, Neuberger JM. Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet 1995:346:1117-1121
93. de Sousa M, Tilney NL, Kupiec-Weglinski JW. Recognition of self within self: specific lymphocyte positioning and the extracellular matrix. Immunol Today 1991:12:262-266
94. Sell S. Is there a liver stem cell? Cancer Res 1990:50:3811-3815
95. Sale GE. Does graft-versus-host disease attack epithelial stem cells? Mol Med Today 1996;2:114-119
96. Bernard PH, Malavialle P, Le Bail B, Carles J, Dumas F, Richard L, et al. Frequency and severity of viral hepatitis C after liver transplantation: study in 28 patients. Gastroenterol Clin Biol 1995:19:692-697
97. Lautenschlager I, Hockerstedt K, Jalanko H, Loginov R, Salmela K, Taskinen E, et al. Persistent cytomegalovirus in liver allografts with chronic rejection. Hepatology 1997;25:190-194
98. Tsuneyama K, Van de Water J, Leung PS, Cha S, Nakanuma Y, Kaplan M, et al. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression. Hepatology 1995;21:1031-1037
99. McCaughan GW, Davies JS, Waugh JA, Bishop GA, Hall BM, Gallagher ND, et al. A quantitative analysis of T lymphocyte populations in human liver allografts undergoing rejection: the use of monoclonal antibodies and double immunolabeling. Hepatology 1990:12:1305-1313
100. Krams SM, Villanueva JC, Quinn MB, Martinez OM. Expression of the cytotoxic T cell mediator granzyme B during liver allograft rejection. Transpl Immunol 1995;3:162-166
101. Hayashi M, Martinez OM, Garcia-Kennedy R, So S, Esquivel CO, Krams SM. Expression of cytokines and immune mediators during chronic liver allograft rejection. Transplantation 1995:60:1533-1538
102. Oguma S, Zerbe T, Banner B, Belle S, Starzl TE, Demetris AJ. Chronic liver allograft rejection and obliterative arteriopathy: possible pathogenic mechanisms. Transplant Proc 1989;21:2203-2207
103. Matsumoto Y, McCaughan GW, Painter DM, Bishop GA. Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection. Transplantation 1993:56:6975
104. Osman Y, Watanabe T, Kawachi Y, Sato K, Ohtsuka K, Watanabe H, et al. Intermediate TCR cells with self-reactive clones are effector cells which induce syngeneic graft-versus-host disease in mice. Cell Immunol 1995:166:172-186
105. Tichelli A, Duell T, Weiss M, Socie G, Ljungman P, Cohen A, et al (European Group or Blood and Marrow Transplantation [EBMT] Working Party on Late Effects). Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. Bone Marrow Transplant 1996;17:1105-1111
106. Demetris AJ, Murase N, Delaney CP, Woan M, Fung JJ, Starzl TE. The liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us? Transplant Proc 1995:27:67-70
107. Demetris AJ, Murase N, Ye Q, Galvao FHF, Richert C, Saad R, et al. Analysis of chronic rejection and obliterative arteriopathy: possible contributions of donor antigen-presenting cells and lymphatic disruption. AmJPathol 1997;150:563-578
108. International Working Party. Terminology for hepatic allograft rejection. Hepatology 1995;22:648-654
109. Williams JW, Foster PF, Sankary HN. Role of liver allograft biopsy in patient management. Semin Liver Dis 1992:12:60-72
110. Porter KA. Pathology of liver transplantation. Transplant Rev 1969:2:129-170
111. Starzl TE, Putnam CW. Experience in Hepatic Transplantation. Philadelphia: Saunders; 1969. pp 422-471
112. Wight DGD. Pathology of rejection. In: Calne RY, editor. Liver Transplantation: The Cambridge-King's College Hospital Experience. New York: Grune & Stratton; 1983. pp 247-277
113. Wight DGD. The morphology of rejection of liver transplants. In: Calne RY, editor. Transplantation Immunology: Clinical and Experimental. Oxford (England): Oxford University Press; 1984. pp 385-435
114. Wight DGD, Portmann B. Pathology of liver transplantation. In: Calne RY, editor. Liver Transplantation. 2nd ed. London: Grune & Stratton; 1987. pp 385-435
115. Portmann B, Neuberger J, Williams R. Intrahepatic bile duct lesions. In: Calne RY, editor. Liver Transplantation: The CambridgeKing's College Hospital Experience. New York: Grune & Stratton; 1983. pp 279-326
116. Portmann B, Wight DGD. Pathology of liver transplantation (excluding rejection). In: Calne RY, editor. Liver Transplantation. 2nd ed. London: Grune & Stratton; 1987. pp 437-470
117. Eggink HF, Hofstee N, Gips CH, Krom RAF, Houthoff HJ. Histopathology of serial graft biopsies from liver transplant recipients. Am J Pathol 1984;114:18-31
118. Williams JW, Peters TG, Vera SR, Britt LG, van Voorst SJ, Haggitt RC. Biopsy-directed immunosuppression following hepatic transplantation in man. Transplantation 1985;39:589-596
119. Williams JW, Vera S, Peters TG, Van Voorst S, Britt LG, Dean PJ, et al. Cholestatic jaundice after hepatic transplantation: a nonimmunologically mediated event. Am J Surg 1986;151:65-70
120. Hubscher SG, Clements D, Elias E, McMaster P. Biopsy findings in cases of rejection of liver allograft. J Clin Pathol 1985:38:1366-1373
121. Hubscher SG. Histological findings in liver allograft rejection-new insights into the pathogenesis of hepatocellular damage in liver allografts. Histopathology 1991;18:377-383
122. Hubscher SG. Pathology of liver allograft rejection. Transpl Immunol 1994;2:118-123
123. Snover DC, Sibley RK, Freese DK, Sharp HL, Bloomer JR, Najarian JS, et al. Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology 1984;4:1212-1222
124. Snover DC, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL. Liver allograft rejection: an analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol 1987;11:1-10
125. Ludwig J. Histopathology of the liver following transplantation. In: Maddrey WC, editor. Transplantation of the Liver. New York: Elsevier; 1988. pp 191-218
126. Kemnitz J, Gubernatis G, Bunzendahl H, Ringe B, Pichlmayr R, Georgii A. Criteria for the histopathological classification of liver allograft rejection and their clinical relevance. Transplant Proc 1989:21:2208-2210
127. Demetris AJ, Lasky S, Van Thiel DH, Starzl TE, Dekker A. Pathology of hepatic transplantation: a review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol 1985:118:151-161
128. Fennell RH Jr, Roddy HJ. Liver transplantation: the pathologist's perspective. Pathol Annu 1979:14:155-182
129. Demetris AJ, Belle SH, Hart J, Lewin K, Ludwig J, Snover DC, et al (Liver Transplantation Database [LTD] Investigators). Intraobserver and interobserver variation in the histopathological assessment of liver allograft rejection. Hepatology 1991;14:751-755
130. Demetris AJ, Seaberg EC, Batts KP, Ferrell LD, Ludwig J, Markin RS, et al. Reliability and predictive value of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database nomenclature and grading system for cellular rejection of liver allografts. Hepatology 1995:21:408-416
131. International Panel. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997:25:658-663
132. Ludwig J, Gross JB Jr, Perkins JD, Moore SB. Persistent centrilobular necroses in hepatic allografts. Hum Pathol 1990:21:656-661
133. Brunt EM, Peters MG, Flye MW, Hanto DW. Day-5 protocol liver allograft biopsies document early rejection episodes and are predictive of recurrent rejection. Surgery 1992;111:511-517
134. Schutt HJ, Nashan B, Krick P, Ringe B, Wittekind C, Wonigeit K, et al. Intragraft immune events after human liver transplantation: correlation with clinical signs of acute rejection and influence of immunosuppression. Transplantation 1992:54:273-278
135. Dousset B, Hubscher SG, Padbury RT, Gunson BK, Buckels JAC, Mayer AD, et al. Acute liver allograft rejection-is treatment always necessary? Transplantation 1993:55:529-534
136. Nakhleh RE, Schwarzenberg SJ, Bloomer J, Payne W, Snover DC. The pathology of liver allografts surviving longer than one year. Hepatology 1990; 11:465-470
137. Hubscher SG, Elias E, Buckels JAC, Mayer AD, McMaster P, Neuberger JM. Primary biliary cirrhosis: histological evidence of disease recurrence after liver transplantation. J Hepatol 1993:18:173-184
138. Pappo 0, Ramos H, Starzl TE, Fung JJ, Demetris AJ. Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol 1995:19:192-206
139. Slapak G, Devlin J, Portmann B, Williams R. Biochemical and histologic study of long-term liver transplant survivors. Transplant Proc 1995:27:1228-1229
140. Slapak GI, Saxena R, Portmann B, Gane E, Devlin J, Calne R, et al. Graft and systemic disease in long-term survivors of liver transplantation. Hepatology 1997;25:195-200
141. Demetris AJ, Todo S, Van Thiel DH, Fung JJ, Iwaki Y, Sysyn G, et al. Evolution of hepatitis B virus liver disease after hepatic replacement: practical and theoretical considerations. Am J Pathol 1990; 137:667-676
142. Demetris AJ, Jaffe R, Sheahan DG, Burnham J, Spero J, Iwatsuki S, et al. Recurrent hepatitis B in liver allograft recipients: differentiation between viral hepatitis B and rejection. Am J Pathol 1986:125:161-172
143. Neuberger J, Portmann B, Macdougall BR, Calne RY, Williams R. Recurrence of primary biliary cirrhosis after liver transplantation. N EnglJ Med 1982;306:l-4
144. Balan V, Batts KP, Porayko MK, Krom RAF, Ludwig J, Wiesner RH. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation. Hepatology 1993;18:1392-1398
145. Emile JF, Sebagh M, Feray C, David F, Reynes M. The presence of epithelioid granulomas in hepatitis C virus-related cirrhosis. Hum Pathol 1993:24:1095-1097
146. Farges 0, Bismuth H, Sebagh M, Reynes M. Granulomatous destruction of bile ducts after liver transplantation: primary biliary cirrhosis recurrence or hepatitis C virus infection? [letter]. Hepatology 1995:21:1765-1767
147. Hoso M, Nakanuma Y, Kawano M, Oda K, Tsuneyama K, van de Water J, et al. Granulomatous cholangitis in chronic hepatitis C: a new diagnostic problem in liver pathology. Pathol Int 1996:46:301-305
148. Randhawa PS, Markin RS, Starzl TE, Demetris AJ. Epstein-Barr virus-associated syndromes in immunosuppressed liver transplant recipients: clinical profile and recognition on routine allograft biopsy. Am J Surg Pathol 1990:14:538-547
149. Randhawa PS, Jaffe R, Demetris AJ, Nalesnik M, Starzl TE, Chen YY, et al. The systemic distribution of Epstein-Barr virus genomes in fatal post-transplantation lymphoproliferative disorders: an in situ hybridization study. Am J Pathol 1991:138:1027-1033
150. Randhawa PS, Jaffe R, Demetris AJ, Nalesnik M, Starzl TE, Chen YY, et al. Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med 1992;327:1710-1714
151. Alshak NS, Jiminez AM, Gedebou M, Thung SN, Podesta L, Nichols WS, et al. Epstein-Barr virus infection in liver transplantation patients: correlation of histopathology and semiquantitative EpsteinBarr virus-DNA recovery using polymerase chain reaction. Hum Pathol 1993:24:1306-1312
152. Telenti A, Smith TF, Ludwig J, Keating MR, Krom RAF, Wiesner RH. Epstein-Barr virus and persistent graft dysfunction after liver transplantation. Hepatology 1991:14:282-286
153. Markin RS, Wood RP, Shaw BW Jr, Brichacek B, Purtilo DT. Immunohistologic identification of Epstein-Barr virus-induced hepatitis reactivation after OKT-3 therapy following orthotopic liver transplant. Am J Gastroenterol 1990;85:1014-1018
154. Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988:133:173-192
155. Nalesnik MA, Makowka L, Starzl TE. The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Probl Surg 1988:25:367-472
156. Demetris AJ, Fung JJ, Todo S, McCauley J, Jain A, Takaya S, et al. Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy-a clinicopathologic study of 96 patients. Transplantation 1992:53:1056-1062
157. McDiarmid SW, Klintmalm GB, Busuttil RW. FK506 conversion for intractable rejection of the liver allograft. Transpl Int 1993;6:305-312
158. Hubscher SG, Buckels JAC, Elias E, McMaster P, Neuberger J. Vanishing bile-duct syndrome following liver transplantation - is it reversible? Transplantation 1991;51:1004-1010
159. White RM, Zajko AB, Demetris AJ, Bron KM, Dekker A, Starzl TE. Liver transplant rejection: angiographic findings in 35 patients. AJR Am J Roentgenol 1987:148:1095-1098
160. Devlin J, Page AC, O'Grady J, Portmann B, Karani J, Williams R. Angiographically determined arteriopathy in liver graft dysfunction and survival. J Hepatol 1993:18:68-73
161. Deligeorgi-Politi H, Wight DGD, Calne RY. Chronic rejection of liver transplants revisited. Transpl Int 1994;7:442-447
162. Demetris AJ, Seaberg EC, Batts KP, Ferrell L, Lee RG, Markin R, et al. Chronic liver allograft rejection: a National Institute of Diabetes and Digestive and Kidney Diseases interinstitutional study analyzing the reliability of current criteria and proposal of an expanded definition. Am J Surg Pathol 1998:22:28-39
163. Harrison RF, Patsiaoura K, Hubscher SG. Cytokeratin immunostaining for detection of biliary epithelium: its use in counting bile ducts in cases of liver allograft rejection. J Clin Pathol 1994; 47:303-308
164. Nakanuma Y, Ohta G. Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis. Gastroenterology 1979:76:1326-1332
165. Wight DGD. Pathology of liver transplantation. In: Wight DGD, editor. Liver, Biliary Tract and Exocrine Pancreas. London: Churchill Livingstone; 1994. pp 543-596
166. Demetris AJ, Zerbe T, Banner B. Morphology of solid organ allograft arteriopathy: identification of proliferating intimal cell populations. Transplant Proc 1989:21:3667-3669
167. Demetris AJ, Markus BH, Burnham J, Nalesnik M, Gordon RD, Makowka L, et al. Antibody deposition in liver allografts with chronic rejection. Transplant Proc 1987;19(Suppl 5):121-125
168. McDonald GB, Shulman HM, Wolford JL, Spencer GD. Liver disease after human marrow transplantation. Semin Liver Dis 1987:7:210-229
169. Snover DC, Weisdorf SA, Ramsay NK, McGlave P, Kersey JH. Hepatic graft versus host disease: a study of the predictive value of liver biopsy in diagnosis. Hepatology 1984;4:123-130
170. Sloane JP, Farthing MJ, Powles RL. Histopathological changes in the liver after allogeneic bone marrow transplantation. J Clin Pathol 1980:33:344-350
171. Sloane JP, Norton J. The pathology of bone marrow transplantation. Histopathology 1993:22:201-209
172. Farthing MJ, Clark ML, Sloane JP, Powles RL, McElwain TJ. Liver disease after bone marrow transplantation. Gut 1982;23:465-474
173. Snover DC. Problems in the interpretation of liver biopsies after liver transplantation. Am J Surg Pathol 1989;13(Suppl l):31-38
174. Nonomura A, Kono N, Yoshida K, Mizukami Y, Nakanuma Y, Matsubara F. Histological changes of the liver in experimental graftversus-host disease across minor histocompatibility barriers. V. A light and electron microscopic study of the intralobular changes. Liver 1991;11:149-157
175. Soderberg C, Larsson S, Bergstedt-Lindqvist S, Moller E. Identification of blood mononuclear cells permissive of cytomegalovirus infection in vitro. Transplant Proc 1993;25:1416-1418
176. Snover DC. Biopsy Diagnosis of Liver Disease. Baltimore: Williams & Wilkins; 1992. pp 217-231
177. Knapp AB, Crawford JM, Rappeport JM, Gollan JL. Cirrhosis as a consequence of graft-versus-host disease. Gastroenterology 1987;92:513-519